People_
Dr Karen Chiam
Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health
Prostate Cancer Stream
The Daffodil Centre
Sydney School of Public Health
Faculty of Medicine and Health
Prostate Cancer Stream
The Daffodil Centre
Websites
Dr Karen Chiam graduated in 2010 with a PhD in Medicine and since then, has been involved in prostate cancer research for more than 10 years. Her past research experience includes research that is focused on identifying new and improved biomarkers and novel treatment therapies in cancer (prostate and oesophageal). Karen is passionate about translating her experience in medical research to real-world changes. To pursue this, she is now focusing on public health research to better understand the needs of prostate cancer patients and what actions are needed, to make a positive impact to their lives.
show more
Prostate Cancer, Epidemiology, Public Health, Cancer genomics, imaging technologies
| Project title | Research student |
|---|---|
| Male breast cancer in NSW: is there an association with subsequent prostate cancer | Basil RAZI |
Publications
Expand all
Journals
- Caruana, M., Grogan, P., Smith, D., O'Connell, D., Canfell, K., Gulati, R., Etzioni, R., Barratt, A., Armstrong, B., Chiam, K., Nair-Shalliker, V., Luo, Q., Bang, S. (2024). Benefits and harms of prostate specific antigen testing according to Australian guidelines. International Journal of Cancer, 154(4), 648-658. [More Information]
- Gallagher, B., Chiam, K., Bang, S., Patel, M., Kench, J., Edwards, S., Nair-Shalliker, V., Smith, D. (2024). Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. Pathology, 56(1), 39-46. [More Information]
- Chiam, K., Crowe, J., Grogan, P., Vaneckova, P., Kohar, A., Mazariego, C., Nair-Shalliker, V., Smith, D. (2023). Making informed decisions about prostate cancer testing Locally tailored factsheets on the burden of prostate cancer in Australia. Australian Journal of General Practice, 52(3), 102-105. [More Information]
show 8 more
Expand all
2024
- Caruana, M., Grogan, P., Smith, D., O'Connell, D., Canfell, K., Gulati, R., Etzioni, R., Barratt, A., Armstrong, B., Chiam, K., Nair-Shalliker, V., Luo, Q., Bang, S. (2024). Benefits and harms of prostate specific antigen testing according to Australian guidelines. International Journal of Cancer, 154(4), 648-658. [More Information]
- Gallagher, B., Chiam, K., Bang, S., Patel, M., Kench, J., Edwards, S., Nair-Shalliker, V., Smith, D. (2024). Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. Pathology, 56(1), 39-46. [More Information]
2023
- Chiam, K., Crowe, J., Grogan, P., Vaneckova, P., Kohar, A., Mazariego, C., Nair-Shalliker, V., Smith, D. (2023). Making informed decisions about prostate cancer testing Locally tailored factsheets on the burden of prostate cancer in Australia. Australian Journal of General Practice, 52(3), 102-105. [More Information]
- Canfell, K., Chiam, K., Nickson, C., Mann, G. (2023). The complex impact of COVID-19 on cancer outcomes in Australia. Medical Journal of Australia, 219(9), 402-404. [More Information]
2022
- Nair-Shalliker, V., Bang, S., Egger, S., Yu, X., Chiam, K., Steinberg, J., Patel, M., Banks, E., O'Connell, D., Armstrong, B., Smith, D. (2022). Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study. British Journal of Cancer, 127(4), 735-746. [More Information]
2021
- Chiam, K., Bang, S., Patel, M., Nair-Shalliker, V., O'Connell, D., Smith, D. (2021). Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men. Cancer Epidemiology Biomarkers and Prevention, 30(9), 1735-1743. [More Information]
- Chiam, K., Carle, C., Hughes, S., Kench, J., Woo, H., Lord, S., Smith, D. (2021). Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios. Prostate Cancer and Prostatic Diseases, 24(3), 662-673. [More Information]
2015
- Mahon, K., Lin, H., Castillo, L., Lee, B., Lee-Ng, K., Chatfield, M., Chiam, K., Breit, S., Brown, D., Molloy, M., Marx, G., Pavlakis, N., Boyer, M., Stockler, M., Horvath, L., et al (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer, 112(8), 1340-1348. [More Information]
- Rynkiewicz, N., Fedele, C., Chiam, K., Gupta, R., Kench, J., Ooms, L., McLean, C., Giles, G., Horvath, L., Mitchell, C. (2015). INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival. The Prostate, 75(1), 92-102. [More Information]
2014
- Lin, H., Castillo, L., Mahon, K., Chiam, K., Lee, B., Nguyen, Q., Boyer, M., Stockler, M., Pavlakis, N., Marx, G., Gurney, H., Horvath, L., et al (2014). Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. British Journal of Cancer, 110(10), 2462-2471. [More Information]
- Birch, S., Kench, J., Takano, E., Chan, P., Chan, A., Chiam, K., Veillard, A., Stricker, P., Haupt, S., Haupt, Y., Horvath, L., et al (2014). Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death. Annals of Oncology, 25(12), 2392-2397. [More Information]